RVXCF Message Board Post 9191590 | Resverlogix Corp
home / stock / rvxcf / rvxcf message board
lovebox
(investorshub)
Posted on: Dec/11/2019 13:32:47
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=152728376
Resverlogix Announces Change to its Board of Directors CALGARY,
News, Short Squeeze, Breakout and More Instantly...
-
Calgary, Alberta--(Newsfile Corp. - May 13, 2024) - Resverlogix Corp. (TSX: RVX) ("Resverlogix" or the "Company") announced today a two-year extension of the Company's US$6.0 million secured convertible debenture with Shenzhen Hepalink Pharmaceutical Group Co., Ltd. ("Hepalink") (and payment of a...
-
2024-03-27 17:08:02 ET Developing safe, epigenetic therapeutics for people suffering from chronic illnesses Resverlogix is a late-stage clinical biotechnology company dedicated to improving the lives of patients with chronic illnesses and providing value-based health solutions...
-
2024-03-27 17:08:02 ET The future of drug development Resverlogix is committed to developing epigenetic therapies for the benefit of patients with chronic disease. Their current clinical program focuses on advancing their lead compound ( apabetalone) and evaluating its th...